BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38708190)

  • 1. Identification of RBM46 as a novel APOBEC1 cofactor for C-to-U RNA-editing activity.
    Wang S; Kim K; Gelvez N; Chung C; Gout JF; Fixman B; Vermulst M; Chen XS
    J Mol Biol; 2023 Dec; 435(24):. PubMed ID: 38708190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-editing the paradigm of Cytidine (C) to Uridine (U) RNA editing.
    Fossat N; Tam PP
    RNA Biol; 2014; 11(10):1233-7. PubMed ID: 25585043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of RNA Editing Activity of APOBEC1-A1CF and APOBEC1-RBM47 Complexes Reconstituted in HEK293T Cells.
    Wolfe AD; Arnold DB; Chen XS
    J Mol Biol; 2019 Mar; 431(7):1506-1517. PubMed ID: 30844405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C to U RNA editing mediated by APOBEC1 requires RNA-binding protein RBM47.
    Fossat N; Tourle K; Radziewic T; Barratt K; Liebhold D; Studdert JB; Power M; Jones V; Loebel DA; Tam PP
    EMBO Rep; 2014 Aug; 15(8):903-10. PubMed ID: 24916387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apobec1 complementation factor (A1CF) and RBM47 interact in tissue-specific regulation of C to U RNA editing in mouse intestine and liver.
    Blanc V; Xie Y; Kennedy S; Riordan JD; Rubin DC; Madison BB; Mills JC; Nadeau JH; Davidson NO
    RNA; 2019 Jan; 25(1):70-81. PubMed ID: 30309881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APOBEC1 complementation factor (A1CF) is dispensable for C-to-U RNA editing in vivo.
    Snyder EM; McCarty C; Mehalow A; Svenson KL; Murray SA; Korstanje R; Braun RE
    RNA; 2017 Apr; 23(4):457-465. PubMed ID: 28069890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live-Cell Quantification of APOBEC1-Mediated RNA Editing: A Comparison of RNA Editing Assays.
    Chieca M; Torrini S; Conticello SG
    Methods Mol Biol; 2021; 2181():69-81. PubMed ID: 32729075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA editing: cytidine to uridine conversion in apolipoprotein B mRNA.
    Chester A; Scott J; Anant S; Navaratnam N
    Biochim Biophys Acta; 2000 Nov; 1494(1-2):1-13. PubMed ID: 11072063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The editosome for cytidine to uridine mRNA editing has a native complexity of 27S: identification of intracellular domains containing active and inactive editing factors.
    Sowden MP; Ballatori N; Jensen KL; Reed LH; Smith HC
    J Cell Sci; 2002 Mar; 115(Pt 5):1027-39. PubMed ID: 11870221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse and other rodent models of C to U RNA editing.
    Blanc V; Davidson NO
    Methods Mol Biol; 2011; 718():121-35. PubMed ID: 21370045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOBEC-1 dependent cytidine to uridine editing of apolipoprotein B RNA in yeast.
    Dance GS; Sowden MP; Yang Y; Smith HC
    Nucleic Acids Res; 2000 Jan; 28(2):424-9. PubMed ID: 10606639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA binding motif 47 (RBM47): emerging roles in vertebrate development, RNA editing and cancer.
    Shivalingappa PKM; Sharma V; Shiras A; Bapat SA
    Mol Cell Biochem; 2021 Dec; 476(12):4493-4505. PubMed ID: 34499322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR structure of the apoB mRNA stem-loop and its interaction with the C to U editing APOBEC1 complementary factor.
    Maris C; Masse J; Chester A; Navaratnam N; Allain FH
    RNA; 2005 Feb; 11(2):173-86. PubMed ID: 15659357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An AU-rich sequence element (UUUN[A/U]U) downstream of the edited C in apolipoprotein B mRNA is a high-affinity binding site for Apobec-1: binding of Apobec-1 to this motif in the 3' untranslated region of c-myc increases mRNA stability.
    Anant S; Davidson NO
    Mol Cell Biol; 2000 Mar; 20(6):1982-92. PubMed ID: 10688645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of protein complexes assembled on apolipoprotein B mRNA for mooring sequence-dependent RNA editing.
    Smith HC
    Methods; 1998 May; 15(1):27-39. PubMed ID: 9614650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of cytidine to uridine editing on cytoplasmic apolipoprotein B mRNA by overexpressing APOBEC-1.
    Yang Y; Sowden MP; Smith HC
    J Biol Chem; 2000 Jul; 275(30):22663-9. PubMed ID: 10833526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-to-U RNA Editing: From Computational Detection to Experimental Validation.
    Lerner T; Kluesner M; Tasakis RN; Moriarity BS; Papavasiliou FN; Pecori R
    Methods Mol Biol; 2021; 2181():51-67. PubMed ID: 32729074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular regulation, evolutionary, and functional adaptations associated with C to U editing of mammalian apolipoproteinB mRNA.
    Anant S; Blanc V; Davidson NO
    Prog Nucleic Acid Res Mol Biol; 2003; 75():1-41. PubMed ID: 14604008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA.
    Mehta A; Kinter MT; Sherman NE; Driscoll DM
    Mol Cell Biol; 2000 Mar; 20(5):1846-54. PubMed ID: 10669759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel role for RNA-binding protein CUGBP2 in mammalian RNA editing. CUGBP2 modulates C to U editing of apolipoprotein B mRNA by interacting with apobec-1 and ACF, the apobec-1 complementation factor.
    Anant S; Henderson JO; Mukhopadhyay D; Navaratnam N; Kennedy S; Min J; Davidson NO
    J Biol Chem; 2001 Dec; 276(50):47338-51. PubMed ID: 11577082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.